about
HomoSAR: bridging comparative protein modeling with quantitative structural activity relationship to design new peptides.Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.Interaction of multimicrobial synthetic inhibitor 1,2-bis(2-benzimidazolyl)-1,2-ethanediol with serum albumin: spectroscopic and computational studies.Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells.Effects of hesperidin, a flavanone glycoside interaction on the conformation, stability, and aggregation of lysozyme: multispectroscopic and molecular dynamic simulation studies?In silico optimization of pharmacokinetic properties and receptor binding affinity simultaneously: a 'parallel progression approach to drug design' applied to β-blockers.Effects of 2-amino-8-hydroxyquinoline interaction on the conformation of physiological isomers of human serum albumin.Interaction of artesunate with β-cyclodextrin: Characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity.How good are ensembles in improving QSAR models? The case with eCoRIA.Design, synthesis, structural characterization by IR, (1) H, (13) C, (15) N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors.Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.Curcumin and kaempferol prevent lysozyme fibril formation by modulating aggregation kinetic parametersDesign, synthesis, and evaluation of 4-(substituted)phenyl-2-thioxo-3,4-dihydro-1H-chromino[4,3-d]pyrimidin-5-one and 4-(substituted)phenyl-3,4-dihydro-1H-chromino[4,3-d]pyrimidine-2,5-dione analogs as antitubercular agentsFuro-fused BINOL based crown as a fluorescent chiral sensor for enantioselective recognition of phenylethylamine and ethyl ester of valine3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignmentEnsemble QSAR: a QSAR method based on conformational ensembles and metric descriptorsSynthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridinesValsartan inclusion by methyl-β-cyclodextrin: thermodynamics, molecular modelling, Tween 80 effect and evaluationTargeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold
P50
Q30009545-73BE14B4-4751-41EE-8608-C28ED63FB532Q34019895-82CF8992-7345-4884-92AC-088A1439B9B0Q34545134-93E8DE54-AE98-4DCC-8DD7-BF4B494852DBQ39050191-09482A66-E51A-4D33-9294-8F799737AC36Q39115902-97C92403-B9E7-4C2A-9B8A-F1120FC7ABACQ41100646-20D5E327-71D4-49EB-9D8C-98E66B1DA0FCQ41244441-176734DC-DDB4-41C8-8722-7B8D0F3BBAF5Q42119016-EF89A507-A551-4CFF-9CA8-962A6700E25FQ42222984-7866480F-111B-4598-877E-7A45951A22DDQ42712986-CD340FF2-FCAB-4741-8308-71DDD140CEA9Q43195999-7320E241-F2B9-4546-B21C-F58C9E7E8E25Q46060678-BFE7DD12-29D4-4F35-AFD5-7266158877A5Q47762028-3CDF5BA5-5448-433B-9CA7-4CFAA7150525Q58967549-5E3D9AC4-8050-4C48-872C-DEE656ABAF06Q63363558-58274F84-0B52-4369-8C63-4CA3836BF45CQ80503880-5B3BD181-07CC-46C1-81B7-D5093E9CA707Q80738467-D1C16989-9A1D-41D2-8975-61E026837189Q83921311-D944CE02-8E62-4C7E-BD57-E301B9C89EE9Q84124677-089FC64B-2A11-47D6-9BE6-CAC196D182A5Q87293968-F16DE547-FB3F-412A-A8BA-56C0E98F555DQ88055960-E47A83FA-34DF-42C3-8A2A-563B8C48AECA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raghuvir R. S. Pissurlenkar
@ast
Raghuvir R. S. Pissurlenkar
@en
Raghuvir R. S. Pissurlenkar
@es
Raghuvir R. S. Pissurlenkar
@nl
type
label
Raghuvir R. S. Pissurlenkar
@ast
Raghuvir R. S. Pissurlenkar
@en
Raghuvir R. S. Pissurlenkar
@es
Raghuvir R. S. Pissurlenkar
@nl
prefLabel
Raghuvir R. S. Pissurlenkar
@ast
Raghuvir R. S. Pissurlenkar
@en
Raghuvir R. S. Pissurlenkar
@es
Raghuvir R. S. Pissurlenkar
@nl
P106
P1153
16550911900
P31
P496
0000-0002-1983-1336